Reconstructed first-round book from the research data, not a scrape of today's website. Public portfolio pages over-report winners, and this graph has the same public-data bias. Investor edges are essentially Crunchbase through late 2015, plus Y Combinator.
Research book · 3-year follow-on
Omnes Capital vs Kairos
Not ranked
Whole-book follow-on hit rate 40.0% (2 of 5 labeled deals). 95% Wilson interval 11.8%–76.9%. Vintage-weighted base rate 50.6%. This is not a fund return.
Not ranked. A book needs at least 15 labeled deals with a vintage base rate. This one has 5.
Vs same-vintage base rate
-10.6 pp
40.0% on 5 deals vs 50.6%
Vs median VC book
-26.2 pp
40.0% on 5 deals vs 66.2%
Vs top-quartile VC
-41.1 pp
40.0% on 5 deals vs 81.1%
Vs Y Combinator
-33.3 pp
40.0% on 5 deals vs 73.3%
Ranked when at least 15 labeled deals have a vintage base rate. Rank is the average-rank percentile of shrunk excess (20 pseudo-deals at that book's vintage base rate) among eligible VC books that clear the same minimum. 100 is best. The whole book is never compared to Kairos's top-50 hit rate.
What Kairos would have said
Scores are the model’s percentile at each company’s first observed funding event, not at a later round. That matches this fund’s entry only when the fund was in the first-round syndicate. A deal is flagged when its percentile clears that vintage’s top-50 cutoff. The whole book is not compared to the top-50 hit rate.
Deals with a score
4
Mean model percentile
40
Flagged deals
0no labeled flagged deals
Companies
5 labeled follow-on deals, 1 matched without an observable label (dropped, not counted as failures).
| Company | Vintage | Follow-on | Kairos percentile | Flagged |
|---|---|---|---|---|
| SuperSonic Imaginesupersonicimagine.fr | 2006 | Yes | 84 | — |
| Adictizadictiz.com | 2012 | No | 54 | — |
| Pixium Visionpixium-vision.com | 2013 | No | 17 | — |
| Unafinance | 2012 | No | 7 | — |
| Gecko Biomedicalgeckobiomedical.com | 2013 | Yes | — | — |
| EyeTechCareeyetechcare.com | 2013 | Unobserved | — | — |